United States Pharmaceuticals

Zentalis Pharmaceuticals Inc (ZNTL)

Track

Track

Zentalis Pharmaceuticals recently recorded a significant purchase of 4,335,000 shares by Walters Group, totaling $15.17 million. This transaction occurred shortly after the company reported its latest results financiers, which missed expectations. Despite a 16.1% decline in stock value over the past quarter, this notable acquisition represents the primary activity observed within the last ninety days.
Ticker: ZNTL Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Zentalis Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
WALTERS GROUP Large shareholder
Transaction date
Purchase
Price
395.60
Quantity 31,274 -30.5%
Value US$2,601,520
1.5
Vultaggio Vincent PAO and PFO Officer
Transaction date
Planned sale
Price
125.13
Quantity 30,346 -20.0%
Value US$1,141,369
2.0
Bruns Ingmar Chief Medical Officer Officer
Transaction date
Sale
Price
405.55
Quantity 50,139 -3.9%
Value US$3,357,912
2.5
EASTLAND JULIA MARIE CEO & President Executive Director
Transaction date
Sale
Price
2.39
Quantity 889 -1.1%
Value US$2,127
1.5
Vultaggio Vincent PAO and PFO Officer
Transaction date
Sale
Price
2.39
Quantity 3,379 -2.2%
Value US$8,086
2.0
Bruns Ingmar Chief Medical Officer Officer
Transaction date
Sale
Price
2.43
Quantity 2,962 -8.1%
Value US$7,197
2.5
EASTLAND JULIA MARIE CEO & President Executive Director
Transaction date
Sale
Price
2.43
Quantity 7,866 -9.0%
Value US$19,112
1.5
Vultaggio Vincent PAO and PFO Officer
Transaction date
Sale
Price
2.43
Quantity 29,951 -16.0%
Value US$72,772
1.5
Vultaggio Vincent PAO and PFO Officer
Transaction date
Planned sale
Price
2.52
Quantity 556 -0.3%
Value US$1,398
1.5
Vultaggio Vincent PAO and PFO Officer
Transaction date
Planned sale
Price
2.52
Quantity 556 -0.3%
Value US$1,398
1.5
Vultaggio Vincent PAO and PFO Officer
Transaction date
Sale
Price
2.55
Quantity 2,540 -1.3%
Value US$6,477
WALTERS GROUP Large shareholder
Transaction date
Purchase
Price
1.20
Quantity 6,459,973 +91.6%
Value US$7,751,968
1.7
Myers Scott Dunseth Non-Executive Director
Transaction date
Purchase
Price
1.40
Quantity 21,000 +8.1%
Value US$29,373
3.4
Cam Gallagher Former Director; Former President & Interim CFO Non-Executive Director
Transaction date
Proposed sale
Price
2.00
Quantity 687
Value US$1,374
2.0
Bruns Ingmar Chief Medical Officer Officer
Transaction date
Purchase
Price
2.28
Quantity 20,000 +120.3%
Value US$45,656
1.5
Vultaggio Vincent PAO and Interim PFO Officer
Transaction date
Sale
Price
1.71
Quantity 2,615 -1.4%
Value US$4,476
3.3
Lackner Mark Chief Scientific Officer Officer
Transaction date
Sale
Price
1.71
Quantity 14,368 -2.7%
Value US$24,591
2.6
Paul Andrea Chief Legal Officer Officer
Transaction date
Sale
Price
1.71
Quantity 13,230 -1.2%
Value US$22,643
3.3
Mark Lackner Chief Scientific Officer Officer
Transaction date
Proposed sale
Price
1.71
Quantity 14,368
Value US$24,591
2.6
Andrea Paul Chief Legal Officer & Corporate Secretary Officer
Transaction date
Proposed sale
Price
1.71
Quantity 13,230
Value US$22,643
3.4
Cam Gallagher Former Director; Former President & Interim CFO Non-Executive Director
Transaction date
Proposed sale
Price
1.71
Quantity 28,558
Value US$48,877
1.5
Skvarka Jan Non-Executive Director
Transaction date
Purchase
Price
1.72
Quantity 60,000 +67.0%
Value US$103,446
1.5
Walker Luke Nathaniel Non-Executive Director
Transaction date
Purchase
Price
1.76
Quantity 14,200 +19.6%
Value US$24,966
2.5
EASTLAND JULIA MARIE CEO & President Executive Director
Transaction date
Purchase
Price
1.73
Quantity 28,500 +inf%
Value US$49,345
3.3
Lackner Mark Chief Scientific Officer Officer
Transaction date
Sale
Price
3.12
Quantity 4,411 -2.3%
Value US$13,762
3.6
Diana Hausman Former Chief Medical Officer Officer
Transaction date
Proposed sale
Price
2.86
Quantity 9,888
Value US$28,294
1.5
Vultaggio Vincent Principal Accounting Officer Officer
Transaction date
Planned sale
Price
3.18
Quantity 1,603 -4.5%
Value US$5,098
3.4
Cam Gallagher Director; Officer - President & Interim CFO Executive Director
Transaction date
Proposed sale
Price
11.98
Quantity 9,597
Value US$114,978
3.4
Gallagher Cam President, Interim CFO Executive Director
Transaction date
Planned sale
Price
11.98
Quantity 9,597 -1.5%
Value US$114,972
3.6
Diana Hausman Chief Medical Officer Officer
Transaction date
Proposed sale
Price
12.62
Quantity 3,356
Value US$42,356
3.6
HAUSMAN DIANA Chief Medical Officer Officer
Transaction date
Sale
Price
12.62
Quantity 3,356 -0.9%
Value US$42,353
Kevin Bunker Former Chief Scientific Officer Officer
Transaction date
Proposed sale
Price
11.44
Quantity 5,478
Value US$62,643
1.2
Melissa Epperly Chief Financial Officer Officer
Transaction date
Proposed sale
Price
11.44
Quantity 2,573
Value US$29,423
3.4
Cam Gallagher President; Director Non-Executive Director
Transaction date
Proposed sale
Price
11.44
Quantity 1,173
Value US$13,414
3.4
Gallagher Cam President Executive Director
Transaction date
Planned sale
Price
11.44
Quantity 1,173 -0.2%
Value US$13,419
1.2
Epperly Melissa B, Chief Financial Officer Officer
Transaction date
Planned sale
Price
11.44
Quantity 2,573 -0.6%
Value US$29,435
2.6
Paul Andrea Chief Legal Officer Officer
Transaction date
Sale
Price
11.54
Quantity 3,310 -2.2%
Value US$38,197
3.3
Lackner Mark Chief Scientific Officer Officer
Transaction date
Sale
Price
11.54
Quantity 1,585 -0.8%
Value US$18,291
1.2
Epperly Melissa B, Chief Financial Officer Officer
Transaction date
Planned sale
Price
11.54
Quantity 8,669 -1.9%
Value US$100,040
3.4
Gallagher Cam President Executive Director
Transaction date
Planned sale
Price
11.54
Quantity 11,552 -1.8%
Value US$133,310
3.3
Mark Lackner Chief Scientific Officer Officer
Transaction date
Proposed sale
Price
11.54
Quantity 1,585
Value US$18,287
2.6
Andrea Paul Chief Legal Officer and Corporate Secretary Officer
Transaction date
Proposed sale
Price
11.54
Quantity 3,310
Value US$38,189
Carrie Brownstein Former Chief Medical Officer Officer
Transaction date
Proposed sale
Price
11.54
Quantity 2,059
Value US$23,756
Kevin Bunker Former Chief Scientific Officer Officer
Transaction date
Proposed sale
Price
11.54
Quantity 11,109
Value US$128,171
1.2
Melissa Epperly Chief Financial Officer Officer
Transaction date
Proposed sale
Price
11.54
Quantity 8,669
Value US$100,019
3.4
Cam Gallagher President; Director Non-Executive Director
Transaction date
Proposed sale
Price
11.54
Quantity 11,552
Value US$133,282
3.2
Blackwell Kimberly Chief Executive Officer Executive Director
Transaction date
Purchase
Price
10.29
Quantity 5,000 +2.0%
Value US$51,448
3.8
Johnson David Michael Non-Executive Director
Transaction date
Purchase
Price
9.88
Quantity 17,000 +13.3%
Value US$167,943
Brownstein Carrie Chief Medical Officer Officer
Transaction date
Planned sale
Price
19.91
Quantity 1,722 -1.6%
Value US$34,285
Brownstein Carrie Chief Medical Officer Officer
Transaction date
Planned sale
Price
19.43
Quantity 8,906 -7.7%
Value US$173,012
1.2
Epperly Melissa B, Chief Financial Officer Officer
Transaction date
Planned sale
Price
19.91
Quantity 888 -0.2%
Value US$17,680
1.2
Epperly Melissa B, Chief Financial Officer Officer
Transaction date
Planned sale
Price
19.43
Quantity 4,594 -1.2%
Value US$89,245
Bunker Kevin D. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
19.91
Quantity 983 -0.1%
Value US$19,572
Bunker Kevin D. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
19.43
Quantity 5,085 -0.6%
Value US$98,784
Carrie Brownstein Chief Medical Officer Officer
Transaction date
Proposed sale
Price
19.50
Quantity 10,628
Value US$207,298
Kevin Bunker Chief Scientific Officer Officer
Transaction date
Proposed sale
Price
19.50
Quantity 6,068
Value US$118,356
1.2
Melissa Epperly Chief Financial Officer Officer
Transaction date
Proposed sale
Price
19.50
Quantity 5,482
Value US$106,926
1.5
Skvarka Jan Non-Executive Director
Transaction date
Planned sale
Price
25.05
Quantity 5,000 -9.4%
Value US$125,238
1.5
JAN SKVARKA Director Non-Executive Director
Transaction date
Proposed sale
Price
25.28
Quantity 5,000
Value US$126,400
3.4
CAM GALLAGHER Director; Officer Executive Director
Transaction date
Proposed sale
Price
26.46
Quantity 18,526
Value US$490,198
3.4
Cam Gallagher Director; Officer - President Executive Director
Transaction date
Proposed sale
Price
26.40
Quantity 9,242
Value US$243,979
3.4
Gallagher Cam President Executive Director
Transaction date
Planned sale
Price
26.21
Quantity 18,526 -3.8%
Value US$485,528
3.4
Gallagher Cam President Executive Director
Transaction date
Planned sale
Price
26.40
Quantity 9,242 -1.9%
Value US$243,979
Bunker Kevin D. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
30.02
Quantity 80,000 -84.2%
Value US$2,401,248
Bunker Kevin D. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
19.98
Quantity 6,500 -0.7%
Value US$129,873
3.4
Gallagher Cam President Executive Director
Transaction date
Planned sale
Price
19.96
Quantity 8,501 -1.7%
Value US$169,706
1.2
Epperly Melissa B, Chief Financial Officer Officer
Transaction date
Planned sale
Price
19.98
Quantity 5,227 -1.3%
Value US$104,411
Bunker Kevin D. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
20.42
Quantity 3,807 -0.4%
Value US$77,756
3.4
Gallagher Cam President Executive Director
Transaction date
Planned sale
Price
20.42
Quantity 3,332 -0.7%
Value US$68,054
1.2
Epperly Melissa B, Chief Financial Officer Officer
Transaction date
Planned sale
Price
20.42
Quantity 2,624 -0.7%
Value US$53,594
3.4
Gallagher Cam President Executive Director
Transaction date
Planned sale
Price
23.04
Quantity 572 -0.1%
Value US$13,176
3.4
Gallagher Cam President Executive Director
Transaction date
Planned sale
Price
22.22
Quantity 9,428 -1.8%
Value US$209,502
3.4
Gallagher Cam President Executive Director
Transaction date
Planned sale
Price
24.87
Quantity 500 -0.1%
Value US$12,434
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-19 2026-08-14 B Purchase
WALTERS GROUP
Large shareholder
31,274 -30.5%
395.60
US$2,601,520 		31,274 -30.5% 395.60 US$2,601,520
2026-02-10 2026-02-10 PlS Planned sale
1.5
Vultaggio Vincent

PAO and PFO

Officer
30,346 -20.0%
125.13
US$1,141,369 		30,346 -20.0% 125.13 US$1,141,369
2026-02-10 2026-02-09 S Sale
2.0
Bruns Ingmar

Chief Medical Officer

Officer
50,139 -3.9%
405.55
US$3,357,912 		50,139 -3.9% 405.55 US$3,357,912
2026-02-10 2026-02-09 S Sale
2.5
EASTLAND JULIA MARIE

CEO & President

Executive Director
889 -1.1%
2.39
US$2,127 		889 -1.1% 2.39 US$2,127
2026-02-10 2026-02-09 S Sale
1.5
Vultaggio Vincent

PAO and PFO

Officer
3,379 -2.2%
2.39
US$8,086 		3,379 -2.2% 2.39 US$8,086
2026-02-10 2026-02-06 S Sale
2.0
Bruns Ingmar

Chief Medical Officer

Officer
2,962 -8.1%
2.43
US$7,197 		2,962 -8.1% 2.43 US$7,197
2026-02-10 2026-02-06 S Sale
2.5
EASTLAND JULIA MARIE

CEO & President

Executive Director
7,866 -9.0%
2.43
US$19,112 		7,866 -9.0% 2.43 US$19,112
2026-02-10 2026-02-06 S Sale
1.5
Vultaggio Vincent

PAO and PFO

Officer
29,951 -16.0%
2.43
US$72,772 		29,951 -16.0% 2.43 US$72,772
2026-02-04 2026-02-03 PlS Planned sale
1.5
Vultaggio Vincent

PAO and PFO

Officer
556 -0.3%
2.52
US$1,398 		556 -0.3% 2.52 US$1,398
2026-02-04 2026-02-03 PlS Planned sale
1.5
Vultaggio Vincent

PAO and PFO

Officer
556 -0.3%
2.52
US$1,398 		556 -0.3% 2.52 US$1,398
2026-02-04 2026-02-02 S Sale
1.5
Vultaggio Vincent

PAO and PFO

Officer
2,540 -1.3%
2.55
US$6,477 		2,540 -1.3% 2.55 US$6,477
2026-01-08 2025-12-31 B Purchase
WALTERS GROUP
Large shareholder
6,459,973 +91.6%
1.20
US$7,751,968 		6,459,973 +91.6% 1.20 US$7,751,968
2025-12-15 2025-12-15 S Sale
1.1
Matrix Capital Management Company, LP
Large shareholder
7,500,000 -53.7%
1.33
US$9,975,000 		7,500,000 -53.7% 1.33 US$9,975,000
2025-04-30 2025-04-30 B Purchase
1.7
Myers Scott Dunseth
Non-Executive Director
21,000 +8.1%
1.40
US$29,373 		21,000 +8.1% 1.40 US$29,373
2025-02-11 2025-02-11 PrS Proposed sale
3.4
Cam Gallagher

Former Director; Former President & Interim CFO

Non-Executive Director
687
2.00
US$1,374 		687 2.00 US$1,374
2025-02-12 2025-02-06 B Purchase
2.0
Bruns Ingmar

Chief Medical Officer

Officer
20,000 +120.3%
2.28
US$45,656 		20,000 +120.3% 2.28 US$45,656
2025-02-05 2025-02-03 S Sale
1.5
Vultaggio Vincent

PAO and Interim PFO

Officer
2,615 -1.4%
1.71
US$4,476 		2,615 -1.4% 1.71 US$4,476
2025-02-05 2025-02-03 S Sale
3.3
Lackner Mark

Chief Scientific Officer

Officer
14,368 -2.7%
1.71
US$24,591 		14,368 -2.7% 1.71 US$24,591
2025-02-05 2025-02-03 S Sale
2.6
Paul Andrea

Chief Legal Officer

Officer
13,230 -1.2%
1.71
US$22,643 		13,230 -1.2% 1.71 US$22,643
2025-02-03 2025-02-03 PrS Proposed sale
3.3
Mark Lackner

Chief Scientific Officer

Officer
14,368
1.71
US$24,591 		14,368 1.71 US$24,591
2025-02-03 2025-02-03 PrS Proposed sale
2.6
Andrea Paul

Chief Legal Officer & Corporate Secretary

Officer
13,230
1.71
US$22,643 		13,230 1.71 US$22,643
2025-02-03 2025-02-03 PrS Proposed sale
3.4
Cam Gallagher

Former Director; Former President & Interim CFO

Non-Executive Director
28,558
1.71
US$48,877 		28,558 1.71 US$48,877
2025-02-04 2025-01-31 B Purchase
1.5
Skvarka Jan
Non-Executive Director
60,000 +67.0%
1.72
US$103,446 		60,000 +67.0% 1.72 US$103,446
2025-02-04 2025-01-31 B Purchase
1.5
Walker Luke Nathaniel
Non-Executive Director
14,200 +19.6%
1.76
US$24,966 		14,200 +19.6% 1.76 US$24,966
2025-02-04 2025-01-31 B Purchase
2.5
EASTLAND JULIA MARIE

CEO & President

Executive Director
28,500 +inf%
1.73
US$49,345 		28,500 +inf% 1.73 US$49,345
2025-01-03 2025-01-02 S Sale
3.3
Lackner Mark

Chief Scientific Officer

Officer
4,411 -2.3%
3.12
US$13,762 		4,411 -2.3% 3.12 US$13,762
2024-10-31 2024-10-31 PrS Proposed sale
3.6
Diana Hausman

Former Chief Medical Officer

Officer
9,888
2.86
US$28,294 		9,888 2.86 US$28,294
2024-10-04 2024-10-04 PlS Planned sale
1.5
Vultaggio Vincent

Principal Accounting Officer

Officer
1,603 -4.5%
3.18
US$5,098 		1,603 -4.5% 3.18 US$5,098
2024-05-31 2024-05-31 PrS Proposed sale
3.4
Cam Gallagher

Director; Officer - President & Interim CFO

Executive Director
9,597
11.98
US$114,978 		9,597 11.98 US$114,978
2024-05-31 2024-05-31 PlS Planned sale
3.4
Gallagher Cam

President, Interim CFO

Executive Director
9,597 -1.5%
11.98
US$114,972 		9,597 -1.5% 11.98 US$114,972
2024-05-09 2024-05-09 PrS Proposed sale
3.6
Diana Hausman

Chief Medical Officer

Officer
3,356
12.62
US$42,356 		3,356 12.62 US$42,356
2024-05-09 2024-05-09 S Sale
3.6
HAUSMAN DIANA

Chief Medical Officer

Officer
3,356 -0.9%
12.62
US$42,353 		3,356 -0.9% 12.62 US$42,353
2024-02-12 2024-02-12 PrS Proposed sale
Kevin Bunker

Former Chief Scientific Officer

Officer
5,478
11.44
US$62,643 		5,478 11.44 US$62,643
2024-02-12 2024-02-12 PrS Proposed sale
1.2
Melissa Epperly

Chief Financial Officer

Officer
2,573
11.44
US$29,423 		2,573 11.44 US$29,423
2024-02-12 2024-02-12 PrS Proposed sale
3.4
Cam Gallagher

President; Director

Non-Executive Director
1,173
11.44
US$13,414 		1,173 11.44 US$13,414
2024-02-12 2024-02-12 PlS Planned sale
3.4
Gallagher Cam

President

Executive Director
1,173 -0.2%
11.44
US$13,419 		1,173 -0.2% 11.44 US$13,419
2024-02-12 2024-02-12 PlS Planned sale
1.2
Epperly Melissa B,

Chief Financial Officer

Officer
2,573 -0.6%
11.44
US$29,435 		2,573 -0.6% 11.44 US$29,435
2024-02-05 2024-02-02 S Sale
2.6
Paul Andrea

Chief Legal Officer

Officer
3,310 -2.2%
11.54
US$38,197 		3,310 -2.2% 11.54 US$38,197
2024-02-05 2024-02-02 S Sale
3.3
Lackner Mark

Chief Scientific Officer

Officer
1,585 -0.8%
11.54
US$18,291 		1,585 -0.8% 11.54 US$18,291
2024-02-05 2024-02-02 PlS Planned sale
1.2
Epperly Melissa B,

Chief Financial Officer

Officer
8,669 -1.9%
11.54
US$100,040 		8,669 -1.9% 11.54 US$100,040
2024-02-05 2024-02-02 PlS Planned sale
3.4
Gallagher Cam

President

Executive Director
11,552 -1.8%
11.54
US$133,310 		11,552 -1.8% 11.54 US$133,310
2024-02-02 2024-02-02 PrS Proposed sale
3.3
Mark Lackner

Chief Scientific Officer

Officer
1,585
11.54
US$18,287 		1,585 11.54 US$18,287
2024-02-02 2024-02-02 PrS Proposed sale
2.6
Andrea Paul

Chief Legal Officer and Corporate Secretary

Officer
3,310
11.54
US$38,189 		3,310 11.54 US$38,189
2024-02-02 2024-02-02 PrS Proposed sale
Carrie Brownstein

Former Chief Medical Officer

Officer
2,059
11.54
US$23,756 		2,059 11.54 US$23,756
2024-02-02 2024-02-02 PrS Proposed sale
Kevin Bunker

Former Chief Scientific Officer

Officer
11,109
11.54
US$128,171 		11,109 11.54 US$128,171
2024-02-02 2024-02-02 PrS Proposed sale
1.2
Melissa Epperly

Chief Financial Officer

Officer
8,669
11.54
US$100,019 		8,669 11.54 US$100,019
2024-02-02 2024-02-02 PrS Proposed sale
3.4
Cam Gallagher

President; Director

Non-Executive Director
11,552
11.54
US$133,282 		11,552 11.54 US$133,282
2023-11-13 2023-11-13 B Purchase
3.2
Blackwell Kimberly

Chief Executive Officer

Executive Director
5,000 +2.0%
10.29
US$51,448 		5,000 +2.0% 10.29 US$51,448
2023-11-13 2023-11-10 B Purchase
3.8
Johnson David Michael
Non-Executive Director
17,000 +13.3%
9.88
US$167,943 		17,000 +13.3% 9.88 US$167,943
2023-10-06 2023-10-04 PlS Planned sale
Brownstein Carrie

Chief Medical Officer

Officer
1,722 -1.6%
19.91
US$34,285 		1,722 -1.6% 19.91 US$34,285
2023-10-06 2023-10-04 PlS Planned sale
Brownstein Carrie

Chief Medical Officer

Officer
8,906 -7.7%
19.43
US$173,012 		8,906 -7.7% 19.43 US$173,012
2023-10-06 2023-10-04 PlS Planned sale
1.2
Epperly Melissa B,

Chief Financial Officer

Officer
888 -0.2%
19.91
US$17,680 		888 -0.2% 19.91 US$17,680
2023-10-06 2023-10-04 PlS Planned sale
1.2
Epperly Melissa B,

Chief Financial Officer

Officer
4,594 -1.2%
19.43
US$89,245 		4,594 -1.2% 19.43 US$89,245
2023-10-06 2023-10-04 PlS Planned sale
Bunker Kevin D.

Chief Scientific Officer

Officer
983 -0.1%
19.91
US$19,572 		983 -0.1% 19.91 US$19,572
2023-10-06 2023-10-04 PlS Planned sale
Bunker Kevin D.

Chief Scientific Officer

Officer
5,085 -0.6%
19.43
US$98,784 		5,085 -0.6% 19.43 US$98,784
2023-10-04 2023-10-04 PrS Proposed sale
Carrie Brownstein

Chief Medical Officer

Officer
10,628
19.50
US$207,298 		10,628 19.50 US$207,298
2023-10-04 2023-10-04 PrS Proposed sale
Kevin Bunker

Chief Scientific Officer

Officer
6,068
19.50
US$118,356 		6,068 19.50 US$118,356
2023-10-04 2023-10-04 PrS Proposed sale
1.2
Melissa Epperly

Chief Financial Officer

Officer
5,482
19.50
US$106,926 		5,482 19.50 US$106,926
2023-09-13 2023-09-11 PlS Planned sale
1.5
Skvarka Jan
Non-Executive Director
5,000 -9.4%
25.05
US$125,238 		5,000 -9.4% 25.05 US$125,238
2023-09-11 2023-09-11 PrS Proposed sale
1.5
JAN SKVARKA

Director

Non-Executive Director
5,000
25.28
US$126,400 		5,000 25.28 US$126,400
2023-06-20 2023-06-20 B Purchase
1.1
Matrix Capital Management Company, LP
Large shareholder
4,760,000 +51.7%
22.66
US$107,861,600 		4,760,000 +51.7% 22.66 US$107,861,600
2023-05-31 2023-05-31 PrS Proposed sale
3.4
CAM GALLAGHER

Director; Officer

Executive Director
18,526
26.46
US$490,198 		18,526 26.46 US$490,198
2023-05-31 2023-05-31 PrS Proposed sale
3.4
Cam Gallagher

Director; Officer - President

Executive Director
9,242
26.40
US$243,979 		9,242 26.40 US$243,979
2023-05-31 2023-05-31 PlS Planned sale
3.4
Gallagher Cam

President

Executive Director
18,526 -3.8%
26.21
US$485,528 		18,526 -3.8% 26.21 US$485,528
2023-05-31 2023-05-31 PlS Planned sale
3.4
Gallagher Cam

President

Executive Director
9,242 -1.9%
26.40
US$243,979 		9,242 -1.9% 26.40 US$243,979
2023-05-31 2023-05-26 PlS Planned sale
Bunker Kevin D.

Chief Scientific Officer

Officer
80,000 -84.2%
30.02
US$2,401,248 		80,000 -84.2% 30.02 US$2,401,248
2023-02-14 2023-02-14 PlS Planned sale
Bunker Kevin D.

Chief Scientific Officer

Officer
6,500 -0.7%
19.98
US$129,873 		6,500 -0.7% 19.98 US$129,873
2023-02-14 2023-02-14 PlS Planned sale
3.4
Gallagher Cam

President

Executive Director
8,501 -1.7%
19.96
US$169,706 		8,501 -1.7% 19.96 US$169,706
2023-02-14 2023-02-14 PlS Planned sale
1.2
Epperly Melissa B,

Chief Financial Officer

Officer
5,227 -1.3%
19.98
US$104,411 		5,227 -1.3% 19.98 US$104,411
2023-02-14 2023-02-13 PlS Planned sale
Bunker Kevin D.

Chief Scientific Officer

Officer
3,807 -0.4%
20.42
US$77,756 		3,807 -0.4% 20.42 US$77,756
2023-02-14 2023-02-13 PlS Planned sale
3.4
Gallagher Cam

President

Executive Director
3,332 -0.7%
20.42
US$68,054 		3,332 -0.7% 20.42 US$68,054
2023-02-14 2023-02-13 PlS Planned sale
1.2
Epperly Melissa B,

Chief Financial Officer

Officer
2,624 -0.7%
20.42
US$53,594 		2,624 -0.7% 20.42 US$53,594
2023-02-06 2023-02-06 PlS Planned sale
3.4
Gallagher Cam

President

Executive Director
572 -0.1%
23.04
US$13,176 		572 -0.1% 23.04 US$13,176
2023-02-06 2023-02-06 PlS Planned sale
3.4
Gallagher Cam

President

Executive Director
9,428 -1.8%
22.22
US$209,502 		9,428 -1.8% 22.22 US$209,502
2023-01-18 2023-01-17 PlS Planned sale
3.4
Gallagher Cam

President

Executive Director
500 -0.1%
24.87
US$12,434 		500 -0.1% 24.87 US$12,434
Explore more

More insider trading research around Zentalis Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America